ILMN

Illumina, Inc.

Healthcare›Medical - Diagnostics & Research|NASDAQ Global Select|US

Price

$127.38

Market Cap

$19.48B

Beta

1.50

P/E

23.2

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)-0.69%

EPS Growth (YoY)+170.56%

Revenue CAGR 3Y-1.78%

P/E Ratio23.2

PEG Ratio0.14

FCF Yield+4.82%

Debt / Equity0.94

Interest Coverage8.7x

No credit card required

Already have an account? Sign in to view the full analysis for ILMN.